• UCLA Health
  • myUCLAhealth
  • School of Medicine
UCLA Obstetrics and Gynecology

UCLA Obstetrics and Gynecology

UCLA Obstetrics and Gynecology
  • About Us
    • Chair's Welcome
    • Contact Us
    • Giving
    • Job Listings
    • News
    • Webinars
  • Clinical Programs
    • Chronic Pelvic Pain Program
    • Family Planning
    • Fertility and Reproductive Health Center
    • Fibroid Treatment Program
    • Gynecologic Oncology
    • Gynecology
    • Maternal Fetal Medicine
    • Nurse Midwives
    • Minimally Invasive & Robotic Surgery
    • Obstetrics
    • Women's Pelvic Health
  • Conditions Treated
    • Cervical Cancer
    • Cervical Insufficiency
    • Congenital Abnormalities
    • Endometriosis
    • Fibroids
    • Hirsutism
    • Infertility
    • Menopause
    • Ovarian Fallopian Tube and Primary Peritoneal Cancer
    • Polycystic Ovary Syndrome (PCOS)
    • Pregnancy
    • Premenstrual Syndrome (PMS)
    • Recurrent Pregnancy Loss
    • Reproductive Surgery
    • Sexually-transmitted Diseases
    • Urinary Incontinence
    • Urinary Tract Infection
    • Uterine / Endometrial Cancer
    • Vaginal Yeast Infection
    • Vulvar and Vaginal Cancer
    • Vulvodynia
  • For Patients
    • Coronavirus
    • Patient Stories
    • myUCLAhealth
    • Appointments
    • Clinical Updates
    • FAQs
    • Find a Doctor
    • First Visit
    • Health Plans
    • Locations
    • Medical Records
    • Patient Videos
    • Physicians Update
    • Pregnancy
    • Prescription Refill
    • Resources
    • Vital Signs Newsletters
    • Webinars
  • Clinical Trials
  • Research
    • Yalda Afshar MD PhD Lab
    • Sandra Orsulic PhD Lab
    • Women's Reproductive Health Research Program
  • Education
    • Residency
    • Fellowship Programs
    • Housestaff Roster 2020-21
    • Calendar of Events
    • Grand Rounds and Conferences
    • Medical Students
    • Aerial Tour: Why Choose UCLA?
    • Contact Academic Office
  • Our Expert Team
    • Appointment Request
    • Chronic Pelvic Pain
    • Family Planning
    • Fertility & Reproductive Health
    • Fibroid Treatment
    • Gynecologic Oncology
    • Gynecology
    • Minimally Invasive & Robotic Surgery
    • Nurse Midwives
    • Obstetrics
    • Maternal Fetal Medicine
    • Women's Pelvic Health
  • UCLA Health
  • myUCLAhealth
  • School of Medicine

UCLA Obstetrics and Gynecology

Daniel Kahn, MD PhD

Daniel Kahn, MD PhD

Daniel Kahn, MD PhD

  • RESEARCH
  • GROUP MEMBERS
  • NEWS
  • PUBLICATIONS
  • PROTOCOLS
  • CONTACT
  • RESEARCH
  • GROUP MEMBERS
  • NEWS
  • PUBLICATIONS
  • PROTOCOLS
  • CONTACT
  1. Home
  2. Research
  3. RESEARCH

RESEARCH

Share this


Trafficking of T regulatory cells to the maternal-fetal interface
Pregnancy is an immunologic paradox:  How does the foreign fetus escape from maternal immune attack?  We, and others, have discovered that the mother uses T regulatory cells with specificity for the fetus to mediate immune tolerance.  Mechanistically, we are learning that the fetus plays an active role in changing the maternal Tregs in such a way that these cells are actively brought to the uteroplacental interface.  Once there, we know that they function to limit the maternal immune attack, but how?  Which cells are they interacting with?  Pregnancy provides a unique opportunity to learn about the fundamental biology of these important cells.   These studies are primarily being done using mice and advanced imaging.  

Preeclampsia as acute fetal rejection
Preeclampsia is a disease unique to human pregnancy.  The only cure is delivery, even when inflicting prematurity on the neonate.  The risk factors (first gestations, changes in paternity, extremes of reproductive age, concomitant autoimmune conditions) suggest an immunologic disorder as part of the fundamental pathology.  We are working on understanding the local factors the influence Treg : NK interactions at the uteroplacental interface during normal and preeclamptic pregnancies.  In addition, we are working on understanding if fundamental Treg functions are altered in preeclamptic pregnancies and why these women aren't all universally at risk for autoimmune disease.

 

Fetal response to maternal antigens  

The fetus has a robust immune system.  What is unique about the fetus is that they make overwhelmingly tolerance type of responses, mainly through Treg activation.  This kind of immune tolerance is long lasting (years).  Thus, if fetuses were to "experience" antigens to which an inflammatory response would be desirable later in life (e.g., infectious antigens), than in utero encounters could have long-lasting counter productive effects.  We are working on understanding the factors, both maternal and fetal, that alter antigen trafficking from the mother to her fetus. 

 

Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Connect with Us on LinkedIn Follow us on Pinterest
UCLA Health hospitals ranked best hospitals by U.S. News & World Report
  • UCLA Health
  • Find a Doctor
  • School of Medicine
  • School of Nursing
  • UCLA Campus
  • Directory
  • Newsroom
  • Subscribe
  • Patient Stories
  • Giving
  • Careers
  • Volunteer
  • International Services
  • Privacy Practices
  • Nondiscrimination
  • Billing
  • Health Plans
  • Emergency
  • Report Broken Links
  • Terms of Use
  • 1-310-825-2631
  • Maps & Directions
  • Contact Us
  • Your Feedback
  • Report Misconduct
  • Get Social
  • Sitemap
Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Connect with Us on LinkedIn Follow us on Pinterest